(Q41615054)

5 October 2017

1 reference

title

Nicotine for the treatment of Tourette's syndrome (English)

1 reference

5 October 2017

Sanberg PR

1

1 reference

5 October 2017

Silver AA

2

1 reference

5 October 2017

Shytle RD

3

1 reference

5 October 2017

Philipp MK

4

1 reference

5 October 2017

Cahill DW

5

1 reference

5 October 2017

Fogelson HM

6

1 reference

5 October 2017

McConville BJ

7

1 reference

5 October 2017

publication date

1 January 1997

1 reference

Pharmacology & Therapeutics

5 October 2017

published in

1 reference

5 October 2017

volume

74

1 reference

5 October 2017

issue

1

1 reference

5 October 2017

page(s)

21-25

1 reference

Normalization of auditory physiology by cigarette smoking in schizophrenic patients

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Influence of nicotine on the release of monoamines in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Electrophysiological actions of nicotine on substantia nigra single units

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Pharmacotherapy of Tourette's syndrome and associated disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Nicotine and Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Tourette's syndrome and nicotine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Longlasting improvement of Tourette's syndrome with transdermal nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Nicotine potentiates haloperidol-induced catalepsy and locomotor hypoactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

The natural history of Tourette syndrome: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Nicotine may relieve symptoms of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Acute tolerance to the locomotor stimulant effects of nicotine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Beneficial effects of nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Clonidine treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Allosteric modulations of the nicotinic acetylcholine receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Persistence of chronic nicotine-induced cognitive facilitation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Nicotine effects on adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Intravenous nicotine in a patient with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

The Gilles de la Tourette syndrome: the current status

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Dopaminergic dysfunction in tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Acetylcholine receptors: too many channels, too few functions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Definitions and classification of tic disorders. The Tourette Syndrome Classification Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Does pharmacology corroborate the nicotine therapy and practices of South American shamanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Presynaptic modulation of transmitter release by nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

Nicotine delivery kinetics and abuse liability

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900199-4

7 January 2021

10.1016/S0163-7258(96)00199-4

Identifiers

DOI

1 reference

5 October 2017

1 reference